Short and long-term outcome in very old patients with ST-elevation myocardial infarction after primary percutaneous

Roberta Sappa1, Maria Teresa Grillo1, Martino Cinquetti2

  • 1Cardiothoracic Department, "Azienda Sanitaria Universitaria Integrata" of Udine, Italy.

Insights

Primary percutaneous coronary intervention (pPCI) is safe for patients aged 85+ with ST-elevation myocardial infarction (STEMI). While long-term survival is good, cardiovascular re-hospitalization remains a concern in this elderly STEMI population.

Area of Science:

  • Cardiology
  • Geriatric Medicine
  • Interventional Cardiology

Background:

  • Octogenarians represent a growing segment of cardiovascular patients.
  • Limited data exist on ST-elevation myocardial infarction (STEMI) outcomes in patients aged 85 years and older.

Purpose of the Study:

  • To evaluate the safety and efficacy of primary percutaneous coronary intervention (pPCI) in patients aged ≥85 years with STEMI.
  • To identify predictors of in-hospital and long-term mortality and re-hospitalization in this elderly population.

Main Methods:

  • Analysis of 126 consecutive patients aged ≥85 years with STEMI undergoing pPCI within 12 hours of symptom onset.
  • Long-term follow-up (median 898 days) for 102 survivors of the index hospitalization.
  • Multivariate analysis to identify independent predictors of mortality and adverse events.

Main Results:

  • In-hospital mortality was 19%. Predictors included nonagenarian status, diabetes, severe left ventricular dysfunction, and intra-aortic balloon pumping.
  • Among survivors, 31% died during follow-up, and 54% were re-hospitalized for cardiovascular causes.
  • Chronic renal failure and a very high bleeding risk independently predicted long-term mortality. Renal function and anterior MI were associated with cardiac mortality and re-hospitalization.

Conclusions:

  • Primary percutaneous coronary intervention (pPCI) is relatively safe in patients aged ≥85 years with STEMI.
  • pPCI offers good long-term survival in this population, though outcomes remain poorer than in younger patients.
  • A significant incidence of cardiovascular re-hospitalization necessitates continued monitoring and management in elderly STEMI patients post-pPCI.
Abstract

Related Concept Videos

Acute Coronary Syndrome I: Introduction01:30

Acute Coronary Syndrome I: Introduction

Acute Coronary Syndrome (ACS) encompasses a spectrum of heart conditions caused by sudden obstruction of coronary arteries, typically resulting from the rupture of an atherosclerotic plaque and subsequent thrombus (blood clot) formation. This obstruction can lead to partial or complete blockage of blood flow, causing varying degrees of myocardial ischemia or infarction.ACS includes the following clinical entities:Unstable Angina (UA)Non-ST-Elevation Myocardial Infarction (NSTEMI)ST-Elevation...
1.2K
Acute Coronary Syndrome IV: Interprofessional Care01:28

Acute Coronary Syndrome IV: Interprofessional Care

IntroductionThe management of Acute Coronary Syndrome (ACS) aims to minimize myocardial damage, preserve myocardial function, and prevent complications.Initial ManagementInpatient management involves continuous cardiac monitoring, preferably in an ICU, focusing on blood pressure, serum sodium, potassium, and creatinine levels, and urine output. Ongoing pharmacologic management is crucial for stabilizing the patient.Supplemental Oxygen: Administer supplemental oxygen if oxygen saturation is...
321
Acute Coronary Syndrome III: Diagnostic Studies01:30

Acute Coronary Syndrome III: Diagnostic Studies

Diagnosing acute coronary syndrome or ACS begins with a thorough patient history. Notable symptoms include central, crushing chest pain radiating to the left arm, neck, jaw, or back, along with shortness of breath, sweating (diaphoresis), nausea, vomiting, dizziness, and palpitations.It is crucial to note any history of cardiac illnesses and assess risk factors, including age, gender, smoking, hypertension, diabetes, hyperlipidemia, and a sedentary lifestyle.During physical examination, vital...
316
Coronary Artery Disease V: Interprofessional Care01:27

Coronary Artery Disease V: Interprofessional Care

Interprofessional care for coronary artery disease includes pharmacological therapy and revascularization procedures.Pharmacological therapy for Coronary Artery Disease (CAD) aims to manage symptoms, prevent complications, and improve patient outcomes through various classes of medications:Antiplatelet Agents:Aspirin and Clopidogrel: These medications inhibit platelet aggregation, preventing blood clots, which is crucial for avoiding heart attacks and strokes. Doctors often prescribe these...
321
Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations01:19

Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations

The pathophysiology of Acute Coronary Syndrome [ACD] involves several key processes:The main underlying cause of ACD is atherosclerosis, a chronic inflammatory disease characterized by the buildup of lipid-laden plaques within the coronary arteries.As the atherosclerotic plaque grows in the coronary artery, it may become unstable due to the formation of a lipid-rich core and a thin fibrous cap. Inflammatory cells within the plaque, such as macrophages, secrete enzymes that degrade the...
494
Peripheral Artery Disease III: Interprofessional Care01:27

Peripheral Artery Disease III: Interprofessional Care

Peripheral Artery Disease (PAD) is characterized by narrowed arteries that diminish blood flow to the extremities. Effective management of PAD requires an interprofessional approach involving various healthcare professionals. The critical aspects of interprofessional care for PAD patients focus on risk factor modification, drug therapy, exercise therapy, nutrition therapy, critical limb ischemia care, and interventional radiology and surgical procedures.The primary treatment goal for PAD...
398